99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging

Molecular Pharmaceutics

Volumn 11, Issue 4, 2014, Pages 1208-1217

  Zhu, Xiaohua ^a,b   Li, Jinbo ^a   Hong, Yeongjin ^a,d   Kimura, Richard H ^a   Ma, Xiaowei ^a   Liu, Hongguang ^a   Qin, Chunxia ^a   Hu, Xiang ^a   Hayes, Thomas R ^c   Benny, Paul ^c   Gambhir, Sanjiv Sam ^a   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Chonnam National University Medical School   (South Korea)

Author keywords

cystine knot peptide; SPECT

Indexed keywords

ALPHAVBETA6 INTEGRIN; RADIOPHARMACEUTICAL AGENT; SINGLE AMINO ACID CHELATE CYSTINE KNOT PEPTIDE TC 99M; UNCLASSIFIED DRUG; INTEGRIN; PEPTIDE; TECHNETIUM COMPLEX; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DISTRIBUTION; EMBRYO; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT; AMINO ACID SEQUENCE; ANIMAL; CYSTINE KNOT MOTIF; EXPERIMENTAL NEOPLASM; FEMALE; MOLECULAR GENETICS; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CYSTINE KNOT MOTIFS; FEMALE; HUMANS; INTEGRINS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84898008856     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400683q     Document Type: Article

References (54)

1. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines Cell 2002, 110 (6) 673-687
2. Volpes, R.; van den Oord, J. J.; Desmet, V. J. Integrins as differential cell lineage markers of primary liver tumors Am. J. Pathol. 1993, 142 (5) 1483-1492
3. Mizejewski, G. J. Role of integrins in cancer: survey of expression patterns Proc. Soc. Exp. Biol. Med. 1999, 222 (2) 124-138
4. Van Waes, C. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing Head Neck 1995, 17 (2) 140-147
5. Eble, J. A.; Haier, J. Integrins in cancer treatment Curr. Cancer Drug Targets 2006, 6 (2) 89-105
6. Pignatelli, M.; Cardillo, M. R.; Hanby, A.; Stamp, G. W. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors Hum. Pathol. 1992, 23 (10) 1159-1166
7. Bandyopadhyay, A.; Raghavan, S. Defining the role of integrin alphavbeta6 in cancer Curr. Drug Targets 2009, 10 (7) 645-652
8. Patsenker, E.; Popov, Y.; Stickel, F.; Jonczyk, A.; Goodman, S. L.; Schuppan, D. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factorbeta activation and retards biliary fibrosis progression Gastroenterology 2008, 135 (2) 660-670
9. Popov, Y.; Patsenker, E.; Stickel, F.; Zaks, J.; Bhaskar, K. R.; Niedobitek, G.; Kolb, A.; Friess, H.; Schuppan, D. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies J. Hepatol. 2008, 48 (3) 453-464
10. Breuss, J. M.; Gallo, J.; DeLisser, H. M.; Klimanskaya, I. V.; Folkesson, H. G.; Pittet, J. F.; Nishimura, S. L.; Aldape, K.; Landers, D. V.; Carpenter, W.; Gillett, N.; Sheppard, D.; Matthay, M. A.; Albelda, S. M.; Kramer, R. H.; Pytela, R. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling J. Cell Sci. 1995, 108 (6) 2241-2251
11. Breuss, J. M.; Gillett, N.; Lu, L.; Sheppard, D.; Pytela, R. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues J. Histochem. Cytochem. 1993, 41 (10) 1521-1527
12. Lee, J. M.; Dedhar, S.; Kalluri, R.; Thompson, E. W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease J. Cell Biol. 2006, 172 (7) 973-981
13. Sipos, B.; Hahn, D.; Carceller, A.; Piulats, J.; Hedderich, J.; Kalthoff, H.; Doodman, S. L.; Kosmahl, M.; Kloppel, G. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong upregulation in pancreatic ductal adenocarcinomas in vivo and in vitro Histopathology 2004, 45 (3) 226-236
14. Xue, H.; Atakilit, A.; Zhu, W.; Li, X.; Ramos, D. M.; Pytela, R. Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro Biochem. Biophys. Res. Commun. 2001, 288 (3) 610-618
15. Regezi, J. A.; Ramos, D. M.; Pytela, R.; Dekker, N. P.; Jordan, R. C. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas Oral Oncol. 2002, 38 (4) 332-336
16. Ahmed, N.; Riley, C.; Rice, G. E.; Quinn, M. A.; Baker, M. S. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer J. Histochem. Cytochem. 2002, 50 (10) 1371-1380
17. Ahmed, N.; Pansino, F.; Clyde, R.; Murthi, P.; Quinn, M. A.; Rice, G. E.; Agrez, M. V.; Mok, S.; Baker, M. S. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade Carcinogenesis 2002, 23 (2) 237-244
18. Kawashima, A.; Tsugawa, S.; Boku, A.; Kobayashi, M.; Minamoto, T.; Nakanishi, I.; Oda, Y. Expression of alphav integrin family in gastric carcinomas: increased alphavbeta6 is associated with lymph node metastasis Pathol. Res. Pract. 2003, 199 (2) 57-64
19. Hazelbag, S.; Kenter, G. G.; Gorter, A.; Dreef, E. J.; Koopman, L. A.; Violette, S. M.; Weinreb, P. H.; Fleuren, G. J. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival J. Pathol. 2007, 212 (3) 316-324
20. Bates, R. C.; Bellovin, D. I.; Brown, C.; Maynard, E.; Wu, B.; Kawakatsu, H.; Sheppard, D.; Oettgen, P.; Mercurio, A. M. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma J. Clin. Invest. 2005, 115 (2) 339-347
21. Elayadi, A. N.; Samli, K. N.; Prudkin, L.; Liu, Y. H.; Bian, A.; Xie, X. J.; Wistuba, I. I.; Roth, J. A.; McGuire, M. J.; Brown, K. C. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer Cancer Res. 2007, 67 (12) 5889-5895
22. Patsenker, E.; Wilkens, L.; Banz, V.; Österreicher, C. H.; Weimann, R.; Eisele, S.; Keogh, A.; Stroka, D.; Zimmermann, A.; Stickel, F. The αvβ6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma J. Hepatol. 2010, 52 (3) 362-369
23. Huang, X.; Sheppard, D. Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of αvβ6. U.S. Patent 7150871, Dec 19, 2006.
24. Kogelberg, H.; Tolner, B.; Thomas, G. J.; Di Cara, D.; Minogue, S.; Ramesh, B.; Sodha, S.; Marsh, D.; Lowdell, M. W.; Meyer, T.; Begent, R. H.; Hart, I.; Marshall, J. F.; Chester, K. Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus J. Mol. Biol. 2008, 382 (2) 385-401
25. Kraft, S.; Diefenbach, B.; Mehta, R.; Jonczyk, A.; Luckenbach, G. A.; Goodman, S. L. Definition of an unexpected ligand recognition motif for alphav beta6 integrin J. Biol. Chem. 1999, 274 (4) 1979-1985
26. Hsiao, J. R.; Chang, Y.; Chen, Y. L.; Hsieh, S. H.; Hsu, K. F.; Wand, C. F.; Tsai, S. T.; Jin, Y. T. Cyclic alphavbeta6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma Head Neck 2010, 32 (2) 160-172
27. Hausner, S. H.; Abbey, C. K.; Bold, R. J.; Gagnon, M. K.; Marik, J.; Marshall, J. F.; Stanecki, C. E.; Sutcliffe, J. L. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model Cancer Res. 2009, 69 (14) 5843-5850
28. 64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide Mol. Imaging 2009, 8 (2) 111-121
29. Kimura, R. H.; Teed, R.; Hackel, B. J.; Pysz, M. A.; Chuang, C. Z.; Sathirachinda, A.; Willmann, J. K.; Gambhir, S. S. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer Clin. Cancer Res. 2012, 18 (3) 839-849
30. Pallaghy, P. K.; Nielsen, K. J.; Craik, D. J.; Norton, R. S. A common structural motif incorporating a cystine knot and a triple-stranded β-sheet in toxic and inhibitory polypeptides Protein Sci. 1994, 3 (10) 1833-1839
31. Colgrave, M. L.; Craik, D. J. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot Biochemistry 2004, 43 (20) 5965-5975
32. Heitz, A.; Avrutina, O.; Le-Nguyen, D.; Diederichsen, U.; Hernandez, J. F.; Gracy, J.; Kolmar, H.; Chiche, L. Knottin cyclization: impact on structure and dynamics BMC Struct. Biol. 2008, 8, 54-73
33. Werle, M.; Schmitz, T.; Huang, H. L.; Wentzel, A.; Kolmar, H.; Bernkop-Schnurch, A. The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery J. Drug Target 2006, 14 (3) 137-146
34. Gracy, J.; Le-Nguyen, D.; Gelly, J. C.; Kaas, Q.; Heitz, A.; Chiche, L. KNOTTIN: the knottin or inhibitor cystine knot scaffold in 2007 Nucl. Acid Res. 2008, 36 (Database issue) D314-D319
35. Lahti, J. L.; Silverman, A. P.; Cochran, J. R. Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein PLoS Comput. Biol. 2009, 5 (9) e1000499
36. Daly, N. L.; Craik, D. J. Bioactive cystine knot proteins Curr. Opin. Chem. Biol. 2011, 15 (3) 362-368
37. Kimura, R. H.; Cheng, Z.; Gambhir, S. S.; Cochran, J. R. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects Cancer Res. 2009, 69 (6) 2435-2442
38. Miao, Z.; Levi, J.; Cheng, Z. Protein Scaffolds Based Molecular Probes for Cancer Molecular Imaging Amino Acids 2011, 41 (5) 1037-1047
39. 18F-Fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6 J. Nucl. Med. 2013, 54 (7) 1101-1105
40. Levadala, M. K.; Banerjee, S. R.; Maresca, K. P.; Babich, J. W.; Zubieta, J. Direct reductive alkylation of amino acids: synthesis of bifunctional chelates for nuclear imaging Synthesis 2004, 11, 1759-1766
41. 177Lu- labeled knottin peptides for integrin receptor-targeted radionuclide therapy Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (4) 613-622
42. Kimura, R. H.; Levin, A. M.; Cochran, F. V.; Cochran, J. R. Engineered cystine knot peptides that bind avβ3, avβ5, and a5β1 integrins with low-nanomolar affinity Proteins 2009, 77 (2) 359-369
43. Kimura, R. H.; Jones, D. S.; Jiang, L.; Miao, Z.; Cheng, Z.; Cochran, J. R. Functional mutation of multiple solvent-exposed loops of the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein PLoS One 2011, 6 (2) e16112
44. 18F for PET imaging of integrin expression Bioconjugate Chem. 2009, 20 (12) 2342-2347
45. Liu, S.; Liu, H.; Ren, G.; Kimura, R. H.; Cochran, J. R.; Cheng, Z. PET imaging of integrin positive tumors using 18F labeled knottin peptides Theranostics 2011, 1, 403-412
46. 64Cu-DOTA-knottin peptide Cancer Res. 2010, 70 (22) 9022-9030
47. 111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis J. Biomed. Biotechnol. 2012, 2012, 368075
48. 3 integrin J. Nucl. Med. 2010, 51 (2) 251-258
49. Jiang, H.; Moore, S. J.; Liu, S.; Liu, H.; Miao, Z.; Cochran, F. V.; Liu, Y.; Tian, M.; Cochran, J. R.; Zhang, H.; Cheng, Z. A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging Amino Acids 2013, 44 (2) 673-681
50. Kimura, R. H.; Miao, Z.; Cheng, Z.; Gambhir, S. S.; Cochran, J. R. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects Bioconjugate Chem. 2010, 21 (3) 436-444
51. Bartholomä, M.; Valliant, J.; Maresca, K. P.; Babich, J.; Zubieta, J. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals Chem. Commun. 2009, 5, 493-512
52. Maresca, K. P.; Hillier, S. M.; Femia, F. J.; Zimmerman, C. N.; Levadala, M. K.; Banerjee, S. R.; Hicks, J.; Sundararajan, C.; Valliant, J.; Zubieta, J.; Eckelman, W. C.; Joyal, J. L.; Babich, J. W. Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC) Bioconjugate Chem. 2009, 20 (8) 1625-1633
53. Maresca, K. P.; Marquis, J. C.; Hillier, S. M.; Lu, G.; Femia, F. J.; Zimmerman, C. N.; Eckelman, W. C.; Joyal, J. L.; Babich, J. W. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide Bioconjugate Chem. 2010, 21 (6) 1032-1042
54. 99mTc) incorporation on the backbone of an α-MSH peptide using a modified-cysteine chelation strategy Bioconjugate Chem. 2012, 23 (11) 2300-2312